Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251

AIDS Research and Human Retroviruses

Volumn 18, Issue 14, 2002, Pages 1081-1088

  Shacklett, Barbara L ^a   Marx, Preston A ^b,c   Ling, Binhua ^b   Veazey, Ronald S ^b   Luckay, Amara ^a   Moretto, Walter J ^a   Wilkens, David T ^c   Jennifer, Hu ^d   Israel, Zimra R ^a   Nixon, Douglas F ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; DNA DETERMINATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOASSAY; LONG TERM EXPOSURE; LYMPHOID TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV SERONEGATIVITY; HUMANS; MACACA MULATTA; POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VAGINA;

EID: 0036389669     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260235434     Document Type: Article

References (44)

1. Royce RA, Sena A, Cates W Jr, and Cohen MS: Sexual transmission of HIV. N Engl J Med 1997;336:1072-1078.
2. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, and Gray RH: Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342: 921-929.
3. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, and Buchbinder SP: Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150:306-311.
4. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
5. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, and Plummer FA: Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758-1765.
6. Israel ZR, Gettie A, Ishizaka ST, Mishkin EM, Staas J, Gilley R, Montefiori D, Marx PA, and Eldridge JH: Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques. AIDS Res Hum Retroviruses 1999;15:1121-1136.
7. Miller CJ, Alexander NJ, Sutjipto S, Lackner AA, Gettie A, Hendrickx AG, Lowenstine LJ, Jennings M, and Marx PA: Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J Virol 1989;63:4277-4284.
8. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolin-sky SM, and Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-225.
9. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamshchikov GV, Chen D, and Eldridge JH: Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323-1327.
10. Eldridge JH, Staas JK, Chen D, Marx PA, Tice TR, and Gilley RM: New advances in vaccine delivery systems. Semin Hematol 1993;30:16-24.
11. Miller CJ, Alexander NJ, Sutjipto S, Joye SM, Hendrickx AG, Jennings M, and Marx PA: Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol 1990;19:401-409.
12. Sutjipto S, Pedersen NC, Miller CJ, Gardner MB, Hanson CV, Gettie A, Jennings M, Higgins J, and Marx PA: Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol 1990;64:2290-2297.
13. Marthas ML, Miller CJ, Sutjipto S, Higgins J, Torten J, Lohman BL, Unger RE, Ramos RA, Kiyono H, McGhee JR, et al.: Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol 1992;21:99-107.
14. Harouse JM, Tan RC, Gettie A, Dailey P, Marx PA, Luciw PA, and Cheng-Mayer C: Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques. Virology 1998;248:95-107.
15. Murphey-Corb M, Wilson LA, Trichel AM, Roberts DE, Xu K, Ohkawa S, Woodson B, Bohm R, and Blanchard J: Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 1999;162:540-549.
16. Moretto WJ, Drohan LA, and Nixon DF: Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry. AIDS 2001;14:2625-2627.
17. Kakimoto WM, Gettie A, Smith S, Donahoe SM, Jin X, Marx P, Connor R, and Nixon DF: Comparison of restimulation methods to elicit SIV specific cytotoxic T-lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors. Immunol Lett 1999;66:135-140.
18. Nixon DF, Donahoe SM, Kakimoto WM, Samuel RV, Metzner KJ, Gettie A, Hanke T, Marx PA, and Connor RI: Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine. Virology 2000;266:203-210.
19. Donahoe SM, Moretto WJ, Samuel RV, Marx PA, Hanke T, Connor RI, and Nixon DF: Direct measurement of CD81 T cell responses in macaques infected with simian immunodeficiency virus. Virology 2000;272:347-356.
20. Zhu T, Corey L, Akridge RE, Change Y, Feng F, Kim J, Alef C, McElroy A, Mullins JI, and McElrath MJ: Evidence for HIV-1 latent infection in exposed seronegative individuals. In: 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, 1999.
21. +-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998;72: 10029-10035.
22. Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, Brookes R, Meyers NJ, and Lehner T: Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol 1996;157:2521-2527.
23. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, and Hendrickx AG: Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 1994;68:6391-6400.
24. Putkonen P, Makitalo B, Bottiger D, Biberfeld G, and Thorstensson R: Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodefi-ciency virus transmission. J Virol 1997;71:4981-4984.
25. + memory T cells. J Exp Med 1997;186:859-865.
26. Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, and Bhardwaj N: A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 1999;13:767-777.
27. + T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 2002;109:837-843.
28. Shacklett BL, Shaw KES, Adamson LA, Wilkens DT, Cox CA, Gardner MB, Sonigo P, and Luciw PA: Live, attenuated SIV-macM4, with point mutations in the Env-TM intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. Submitted (2002).
29. Operskalski EA, Stram DO, Busch MP, Huang W, Harris M, Dietrich SL, Schiff ER, Donegan E, and Mosley JW: Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol 1997;146:655-661.
30. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, and Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-1019.
31. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, Mac-Donald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
32. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Ball TB, Oyugi J, Njagi E, Gaur LK, Brunham RC, Wade J, Luscher MA, Krausa P, Rowland-Jones S, Ngugi E, Bwayo JJ, and Plummer FA: Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581-1589.
33. Keet IPM, Tang J, Klein MR, LeBlanc S, Enger C, Rivers C, Apple RJ, Mann D, Goedert JJ, Miedema F, and Kaslow RA: Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1999;180:299-309.
34. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, and O'Brien SJ: HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
35. Chen Z, Gettie A, Ho DD, and Marx PA: Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in West Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 1998;246:113-124.
36. Palacios E, Digilio L, McClure HM, Chen Z, Marx PA, Goldsmith MA, and Grant RM: Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol 1998;8:943-946.
37. Evans DT, Jing P, Allen TM, O'Connor DH, Horton H, Venham JE, Piekarczyk M, Dzuris J, Dykhuzen M, Mitchen J, Rundersdorf RA, Pauza CD, Sette A, Bontrop RE, DeMars R, and Watkins DI: Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: Evidence for an influence on disease progression. J Virol 2000;74:7400-7410.
38. Pal R, Venzon D, Letvin NL, Santra S, Montefiori DC, Miller NR, Tryniszewska E, Lewis MG, VanCott TC, Hirsch V, Woodward R, Gibson A, Grace M, Dobratz E, Markham PD, Hel Z, Nacsa J, Klein M, Tartaglia J, and Franchini G: ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 2002;76:292-302.
39. Wilson LA, Murphey-Corb M, Martin LN, Harrison RM, Ratterree MS, and Bohm RP: Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta). J Med Primatol 2000;29:173-181.
40. + cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge. Scand J Immunol 2001;53:245-253.
41. Ahmed RK, Nilsson C, Wang Y, Lehner T, Biberfeld G, and Thorstensson R: β-Chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge. J Gen Virol 1999; 80:1569-1574.
42. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, Morton WR, Shearer GM, and Benveniste RE: T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994;8:1391-1395.
43. + lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001;107:1303-1310.
44. + T cell responses in exposed, seronegative women. AIDS Res Hum Retroviruses 2002;18(11):805-815.